Blood content of asymmetric dimethylarginine: new insights into its dysregulation in renal disease.
BACKGROUND
Plasma asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase, is significantly elevated in patients with kidney disease and is a potential risk factor for cardiovascular disease. Here, we tested whether human whole blood (WB), as in rodent blood, can accumulate free ADMA and whether this accumulation is a function of disease burden.


METHODS
In 16 healthy control subjects (CO), 18 patients with ESRD and 18 matched hypertensive patients with normal renal function (HTN), we compared using high-pressure liquid chromatography baseline plasma and WB supernatant (WBSUP) ADMA and symmetrical dimethylarginine (SDMA) concentrations and accumulation during a 5-h incubation. We measured protein turnover in incubated WBSUP to determine if proteolytic processes drive ADMA accumulation.


RESULTS
Elevated plasma ADMA was confirmed in ESRD and HTN populations while basal WBSUP ADMA was significantly higher in ESRD subjects than controls (P = 0.05 versus CO; P = 0.02 versus HTN). Plasma SDMA followed a similar pattern. Incubation of WBSUP resulted in ADMA release from protein-incorporated stores while SDMA was unaffected. ADMA accumulation in ESRD samples was significantly greater than that in HTN (P = 0.03). CO and HTN men showed significantly greater ADMA accumulation than women (P = 0.01 and P = 0.003, respectively) but no gender difference was observed in the ESRD group (P = 0.26). ADMA accumulation correlated with ex vivo protein turnover (R = 0.76, P < 0.0001).


CONCLUSIONS
Human blood is capable of releasing physiologically significant quantities of ADMA via proteolytic pathways. Dysregulated ADMA release from WB reservoirs may contribute to the distinctly high plasma ADMA levels in ESRD populations.
Billecke
Scott S
SS
University of Michigan Medical School, Simpson Memorial Institute, Rm 310, 102 Observatory Road, Ann Arbor, MI 48109-5725, USA.
D'Alecy
Louis G
LG
Platel
Raylene
R
Whitesall
Steven E
SE
Jamerson
Kenneth A
KA
Perlman
Rachel L
RL
Gadegbeku
Crystal A
CA
D000328:Adult; D001120:Arginine / Q000031:analogs & derivatives* / Q000097:blood; D015415:Biomarkers / Q000097:blood; D016022:Case-Control Studies; D004912:Erythrocytes / Q000378:metabolism; D005260:Female; D006801:Humans; D006973:Hypertension / Q000097:blood; D007676:Kidney Failure, Chronic / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010447:Peptide Hydrolases / Q000097:blood; D010949:Plasma / Q000378:metabolism
D015415:Biomarkers; C024917:symmetric dimethylarginine; C018524:N,N-dimethylarginine; D001120:Arginine; D010447:Peptide Hydrolases
J Am Soc Nephrol. 2004 Feb;15(2):435-41
14747391
Acta Pharmacol Sin. 2004 Dec;25(12):1633-9
15569408
Arch Biochem Biophys. 1987 Feb 1;252(2):526-37
3101600
Circulation. 2002 Aug 6;106(6):653-8
12163423
Blood Purif. 2003;21(1):29-36
12566658
Nitric Oxide. 1997 Feb;1(1):65-73
9701046
Diabetologia. 2006 Feb;49(2):351-9
16369774
Lancet. 2001 Dec 22-29;358(9299):2113-7
11784625
Jpn Circ J. 2001 Sep;65(9):775-8
11548874
J Am Soc Nephrol. 1999 Mar;10(3):594-600
10073610
Atheroscler Suppl. 2003 Dec;4(4):33-40
14664901
J Am Soc Nephrol. 2006 Apr;17(4):1128-34
16481412
Am J Kidney Dis. 1998 Nov;32(5):853-906
9820460
J Biol Chem. 1989 Jun 15;264(17):10205-9
2722865
J Am Soc Nephrol. 2005 Aug;16(8):2456-61
15930091
Eukaryot Cell. 2007 Jun;6(6):889-98
17468392
Nephrol Dial Transplant. 2001 Feb;16(2):302-6
11158404
Diabetes Care. 2004 Mar;27(3):765-9
14988299
Kidney Int. 2006 Aug;70(4):781-7
16820789
J Nutr. 2006 Jul;136(7):1792-9
16772439
Anal Biochem. 2006 May 15;352(2):274-81
16600169
Biochim Biophys Acta. 1953 Mar;10(3):414-26
13058999
Ann Hematol. 2005 May;84(5):282-6
15599544
Circulation. 2000 Apr 25;101(16):1899-906
10779454
J Am Soc Nephrol. 2005 Apr;16(4):892-8
15728783
Am Heart J. 2004 Jul;148(1):e5
15215814
Nephrol Dial Transplant. 2008 May;23(5):1513-20
18204093
Am J Cardiol. 2004 Jul 15;94(2):157-61
15246890
Biochem Pharmacol. 2002 Apr 1;63(7):1259-72
11960602
Clin Endocrinol (Oxf). 2005 Aug;63(2):203-6
16060915
Kidney Int Suppl. 2003 May;(84):S50-3
12694308
Am J Physiol Heart Circ Physiol. 2006 Jan;290(1):H209-16
16113067
Am J Hypertens. 2002 Jul;15(7 Pt 1):590-3
12118904
Am J Kidney Dis. 1999 Aug;34(2):228-34
10430967
Metabolism. 1979 Aug;28(8):801-4
454517
Cardiovasc Res. 2001 Mar;49(4):697-712
11230969
J Am Soc Nephrol. 2005 Aug;16(8):2449-55
15944335
Clin Chim Acta. 2003 Oct;336(1-2):1-12
14500028
Lancet. 2001 Dec 22-29;358(9299):2096-7
11784617
Am J Physiol Heart Circ Physiol. 2006 Oct;291(4):H1788-96
16632550
Free Radic Res. 2001 Dec;35(6):693-707
11811522
Am J Kidney Dis. 2005 Aug;46(2):186-202
16112037
J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Jun 15;805(2):325-9
15135108
Scand J Clin Lab Invest. 2007;67(8):868-76
17852822
Scand J Immunol. 2007 Jun;65(6):525-9
17523944
Am J Physiol Renal Physiol. 2006 Nov;291(5):F932-44
16885153
Nephrol Dial Transplant. 2008 Feb;23(2):734-40
18175783
Nephrol Dial Transplant. 2006 Sep;21(9):2446-51
16766542
Kidney Int Suppl. 2001 Feb;78:S9-13
11168975
Kidney Int. 1997 Aug;52(2):468-72
9264003
Circ J. 2002 Sep;66(9):811-5
12224817
Kidney Int. 2001 Sep;60(3):1077-82
11532102